1-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]-3-[6-(4-ethylpiperazin-1-yl)pyridin-3-yl]-Nmethyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine

ID: ALA4217649

PubChem CID: 145974023

Max Phase: Preclinical

Molecular Formula: C27H31N11

Molecular Weight: 509.62

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1

Standard InChI:  InChI=1S/C27H31N11/c1-3-35-11-13-36(14-12-35)24-10-9-21(15-29-24)25-23-16-30-27(28-2)31-26(23)38(33-25)19-22-18-37(34-32-22)17-20-7-5-4-6-8-20/h4-10,15-16,18H,3,11-14,17,19H2,1-2H3,(H,28,30,31)

Standard InChI Key:  PAZDHXLZWBCXCX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   33.3425   -6.0340    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.3413   -6.8535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0494   -7.2625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.0476   -5.6251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7562   -6.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7610   -6.8490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5410   -7.0974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0184   -6.4323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.5333   -5.7729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7817   -4.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5814   -4.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8294   -4.0466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2788   -3.4416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4769   -3.6196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2326   -4.3972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5305   -2.6659    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.3299   -2.4920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5777   -1.7170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0294   -1.1105    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2299   -1.2845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9788   -2.0648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7981   -7.8731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2548   -8.4836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4414   -8.4053    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.1134   -9.1537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.7239   -9.6970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.4291   -9.2842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6333   -7.2615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.9259   -6.8524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6432  -10.5102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8987  -10.8470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2370  -10.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4930  -10.7028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4119  -11.5169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0808  -11.9936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8221  -11.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2792   -0.3325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0780   -0.1598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  9 10  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 13 16  1  0
  7 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 23  2  0
  2 28  1  0
 28 29  1  0
 26 30  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
 19 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4217649

    ---

Associated Targets(Human)

TYRO3 Tchem Tyrosine-protein kinase receptor TYRO3 (2906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RET Tclin Tyrosine-protein kinase receptor RET (6732 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MERTK Tchem Proto-oncogene tyrosine-protein kinase MER (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AXL Tchem Tyrosine-protein kinase receptor UFO (3469 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 509.62Molecular Weight (Monoisotopic): 509.2764AlogP: 2.76#Rotatable Bonds: 8
Polar Surface Area: 105.71Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.71CX LogP: 3.31CX LogD: 2.83
Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.34Np Likeness Score: -2.16

References

1. Myers SH, Temps C, Houston DR, Brunton VG, Unciti-Broceta A..  (2018)  Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening.,  61  (5): [PMID:29466002] [10.1021/acs.jmedchem.7b01605]

Source